183 related articles for article (PubMed ID: 2437333)
1. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
Keillor JS; Aterman K
J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Epstein JI; Eggleston JC
Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
[TBL] [Abstract][Full Text] [Related]
3. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
[TBL] [Abstract][Full Text] [Related]
4. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.
Warhol MJ; Longtine JA
J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
Steffens J; Friedmann W; Lobeck H
Eur Urol; 1985; 11(2):91-4. PubMed ID: 2408895
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of prostatic acid phosphatase and prostatic specific antigen in prostatic carcinoma--a comparison of monoclonal antibody to polyclonal antibody].
Moriyama N; Taniguchi J; Hara M; Fukutani K; Matsushima H; Murakami T; Isurugi K; Kawabe K; Niijima T
Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):1992-7. PubMed ID: 2453695
[No Abstract] [Full Text] [Related]
7. Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.
Stein BS; Vangore S; Petersen RO
Urology; 1984 Aug; 24(2):146-52. PubMed ID: 6205496
[TBL] [Abstract][Full Text] [Related]
8. Biological markers in prostate cancer.
Pontes JE
J Urol; 1983 Dec; 130(6):1037-47. PubMed ID: 6196490
[No Abstract] [Full Text] [Related]
9. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Allhoff EP; Proppe KH; Chapman CM; Lin CW; Prout GR
J Urol; 1983 Feb; 129(2):315-8. PubMed ID: 6339742
[TBL] [Abstract][Full Text] [Related]
11. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
13. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
Svanholm H
Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
[TBL] [Abstract][Full Text] [Related]
16. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?
Morote J; Ruibal A; Pascual C; Palou J; de Torres JA
J Urol; 1987 May; 137(5):891-3. PubMed ID: 2437332
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer.
Cohen RJ; Glezerson G; Haffejee Z
Arch Pathol Lab Med; 1992 Jan; 116(1):65-6. PubMed ID: 1370878
[TBL] [Abstract][Full Text] [Related]
19. [Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB].
Morishita N; Minami Y; Ogawa S; Saito Y
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):404-13. PubMed ID: 6206268
[No Abstract] [Full Text] [Related]
20. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Ellis DW; Leffers S; Davies JS; Ng AB
Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
